Zoonotic

Influenza A/Astrakhan/3212/2020 (H5N8)-like strain (Cber-Rg8a) vaccine provides protection against avian influenza virus clade 2.3.4.4b. This inactivated vaccine is designed for intramuscular administration to reduce seasonal flu risks. Available for EU-sourced supply.

This vaccine targets Influenza A subtype H5N8, a zoonotic strain with pandemic potential. It is used to prevent infection in individuals at risk of exposure to avian influenza viruses. The vaccine aligns with WHO recommendations for clade 2.3.4.4b strains.

After administration, the immune system develops antibodies against the H5N8-like strain. Most recipients experience mild local reactions, such as soreness at the injection site. Systemic effects like fatigue or headache may occur temporarily.

Store refrigerated between 2°C and 8°C. Avoid freezing. Discard if vaccine appears discolored or contains particles. Keep out of reach of children. Consult a healthcare provider if you have severe allergies or are immunocompromised.

No known interactions with other vaccines or medications are reported. However, immunosuppressive therapies may reduce vaccine efficacy. Alcohol does not impact the vaccine’s effectiveness but may worsen local reactions.